Department of Gastroenterology, Sun Yai-Sen Memorial Hospital, Sun Yai-Sen University, 14th Floor of Lingnan Building, No. 107, Yanjiang West Road, 510000 Guangzhou, China.
Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):583-91. doi: 10.1016/j.clinre.2012.04.014. Epub 2012 Jun 14.
The Child-Pugh score, the model for end-stage liver disease (MELD) score, and the occurrence of cirrhosis-related complications are independent prognostic predictors used in the assessment of chronic liver diseases.
The objectives of this study were to determine the best prognostic scoring system, and to create a combined method to predict the prognosis of liver cirrhosis more accurately.
We retrospectively reviewed 435 cirrhotic patients from January 2009 to June 2010 and evaluated their short- and medium-term survival. Child-Pugh, MELD and its advanced scoring systems were computed for each patient. The sensitivity and specificity of these scoring systems were analyzed and their validity was assessed using concordance (c)-statistics in predicting the prognosis of cirrhotic patients.
Overall, 107 patients died within 6 months and 150 patients died within 1 year. The clinical and biochemical characteristics, cirrhosis-related complications, and the scores were significantly different among the survivors and patients who died. The largest area under the receiver operating characteristic curve was 0.741 for the integrated MELD (iMELD) at 6 months and 0.713 for iMELD at 12 months, indicating that iMELD was the best scoring system tested. Given this result, we created a new scoring system that combined iMELD and an index of cirrhosis-related complications, called iMELD-C. This novel system had c indexes of 0.758 for the 6-month survival and 0.746 for the 1-year survival.
The iMELD-C score is a better predictor of both short- and medium-term survival in patients with cirrhosis.
Child-Pugh 评分、终末期肝病模型(MELD)评分和肝硬化相关并发症的发生是评估慢性肝病的独立预后预测指标。
本研究旨在确定最佳预后评分系统,并创建一种联合方法以更准确地预测肝硬化的预后。
我们回顾性分析了 2009 年 1 月至 2010 年 6 月期间的 435 例肝硬化患者,并评估了他们的短期和中期生存情况。为每位患者计算了 Child-Pugh、MELD 及其高级评分系统。分析了这些评分系统的敏感性和特异性,并使用一致性(c)统计评估了它们在预测肝硬化患者预后方面的有效性。
总体而言,107 例患者在 6 个月内死亡,150 例患者在 1 年内死亡。幸存者和死亡患者的临床和生化特征、肝硬化相关并发症以及评分均存在显著差异。6 个月时综合 MELD(iMELD)的最大受试者工作特征曲线下面积为 0.741,12 个月时 iMELD 的最大面积为 0.713,表明 iMELD 是测试的最佳评分系统。鉴于这一结果,我们创建了一种新的评分系统,将 iMELD 与肝硬化相关并发症指数相结合,称为 iMELD-C。该新系统在 6 个月生存率的 c 指数为 0.758,1 年生存率的 c 指数为 0.746。
iMELD-C 评分是预测肝硬化患者短期和中期生存率的更好指标。